
Anlon Healthcare IPO
- Issue price
- ₹91
- Listing price
- ₹92
- +1.10%
- Current price
- ₹26.94
- +196.04%
- Subscribed
- 7.12x
- Issue size
- ₹121.03 Cr
- Listed on
- 3 Sep 2025
IPO timeline
- Opens26 AugTue
- Closes29 AugFri
- Allotment1 SepMon
- Refunds2 SepTue
- Demat credit2 SepTue
- Listing3 SepWed
Issue details
- Price band
- ₹86 – ₹91 per share
- Issue size
- ₹121.03 Cr
- Fresh issue
- ₹121.03 Cr · 1.33 Cr shares
- Offer for sale
- None
- Issue type
- Fresh capital only
- Face value
- ₹10 per share
- Lot size
- 164 shares
- Minimum investment
- ₹14,924
- Listing on
- BSE, NSE
- Exchange code
- AHCL · 544497
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 164 | ₹14,924 |
| Retail (Max) | 13 | 2,132 | ₹1,94,012 |
| S-HNI (Min) | 14 | 2,296 | ₹2,08,936 |
| B-HNI (Min) | 68 | 11,152 | ₹10,14,832 |
Reservation
- QIB
- 99,75,000 shares (75.00% of the Offer)
- NII
- 19,95,000 shares (15.00% of the Offer)
- Retail
- 13,30,000 shares (10.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 1 Sep 2025
- Refunds initiated
- 2 Sep 2025
- Shares credited to demat
- 2 Sep 2025
- Listing
- 3 Sep 2025
Grey market premium (GMP)
- Current GMP
- ₹2
- +2.00%
- Estimated listing price
- ₹93
- Issue price ₹91
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB1.07x
- NII (HNI)10.61x
- Retail47.26x
Financials
- P/E (pre-issue)
- 17.67
- P/E (post-issue)
- 23.57
- EPS (₹)
- 3.86
- RoE
- 40.45%
- RoCE
- 21.93%
- RoNW
- 25.51%
- PAT Margin
- 17.06%
- EBITDA Margin
- 26.88%
- Debt / Equity
- 0.73
- NAV (₹)
- 20.18
Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price on profit for the FY ended 31 Mar 2025.
| Period ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 181.30 | 128.00 | 111.55 |
| Total Income | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| EBITDA | 32.38 | 15.57 | 12.66 |
| NET Worth | 80.42 | 21.03 | 7.37 |
| Reserves and Surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Anlon Healthcare This IPO | ₹121.03 Cr | 23.57 | 25.51% | 17.06% | 7.12x | +1.10% |
| Amanta Healthcare Mainboard · listed 9 Sep 2025 | ₹126 Cr | 46.59 | 10.89% | 3.86% | 82.6x | +7.14% |
| Kronox Lab Sciences Mainboard · listed 10 Jun 2024 | ₹130.15 Cr | 24.47 | 25.66% | 22.60% | 117.25x | +21.29% |
| Hexagon Nutrition Mainboard · listed 12 Jun 2026 | ₹138.87 Cr | 15.35 | 12.12% | 9.81% | 53.68x | +7.22% |
| Gaudium IVF Mainboard · listed 27 Feb 2026 | ₹165 Cr | 22.99 | 41.71% | 26.96% | 7.27x | +5.06% |
| Gujarat Kidney & Super Speciality Mainboard · listed 30 Dec 2025 | ₹250.8 Cr | 61.62 | 36.61% | 23.61% | 5.21x | +5.26% |
| Sai Parenteral's Mainboard · listed 2 Apr 2026 | ₹409 Cr | 72.19 | 5.09% | 8.93% | 1.08x | +2.04% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Anlon Healthcare plans to use the money raised, as stated in the offer document.
- Funding capital expenditure requirements for Proposed Expansion₹30.72 Cr
- Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company₹5 Cr
- Funding the working capital requirements of the Company₹43.15 Cr
- General Corporate Purposes₹27.03 Cr
- Issue Expenses₹15.13 Cr
About Anlon Healthcare
Anlon Healthcare Limited was incorporated in 2013. It is a chemical manufacturing company that makes high-purity pharmaceutical intermediates and active pharmaceutical ingredients. These products are raw materials for medicines such as tablets, capsules, ointments and syrups. They are also used in nutraceuticals, personal care and animal health products. The products are manufactured to pharmacopeia standards including IP, BP, EP, JP and USP. The company also offers custom manufacturing of complex chemicals. The IPO was a fresh issue of Rs 121.03 crore. Rs 43.15 crore was planned for working capital and Rs 30.72 crore for expansion.
Strengths
- Profit after tax rose from Rs 5.82 crore in FY2023 to Rs 20.52 crore in FY2025.
- The PAT margin was 17.06% and the EBITDA margin was 26.88%.
- Net worth rose from Rs 7.37 crore on 31 March 2023 to Rs 80.42 crore on 31 March 2025.
- The whole Rs 121.03 crore issue was fresh capital.
- Return on equity was 40.45% and return on capital employed was 21.93%.
Risks
- Total income fell from Rs 113.12 crore in FY2023 to Rs 66.69 crore in FY2024 before recovering to Rs 120.46 crore in FY2025, so income can swing.
- Return on equity of 40.45% is high partly because net worth was small, at Rs 21.03 crore on 31 March 2024.
- The P/E was 23.57 at the upper band of Rs 91, based on post-issue EPS of Rs 3.86.
- Total borrowing was Rs 58.35 crore on 31 March 2025, and debt to equity was 0.73.
- The company is small, with total assets of Rs 181.30 crore on 31 March 2025.
- Rs 43.15 crore of the proceeds was for working capital.
- Promoters held 70.26% before the issue and held 52.68% after it.
Promoters and shareholding
Punitkumar R. Rasadia, Meet Atulkumar Vachhani and Mamata Punitkumar Rasadia
- Promoter holding, pre-issue
- 70.26%
- Promoter holding, post-issue
- 52.68%
Registrar, lead managers and documents
Lead manager
Anlon Healthcare IPO: common questions
1.When does the Anlon Healthcare IPO open and close?
The Anlon Healthcare IPO opens on 26 Aug 2025 and closes on 29 Aug 2025.
2.What is the price band of the Anlon Healthcare IPO?
The price band is ₹86 – ₹91 per share, with a lot size of 164 shares and a minimum investment of ₹14,924.
3.What is the size of the Anlon Healthcare IPO?
The issue size is ₹121.03 Cr (Fresh capital only).
4.What is the GMP of the Anlon Healthcare IPO?
The last reported grey market premium is ₹2 per share as of 29 Aug 2025, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Anlon Healthcare IPO allotment?
The basis of allotment is expected on 1 Sep 2025. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Anlon Healthcare IPO list?
The shares listed on 3 Sep 2025 on BSE, NSE.
7.Who is the lead manager of the Anlon Healthcare IPO?
The book running lead manager is Interactive Financial Services Ltd., and the registrar is KFin Technologies Limited.
8.What will the money raised in the Anlon Healthcare IPO be used for?
As stated in the offer document, the proceeds are for: Funding capital expenditure requirements for Proposed Expansion; Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company; Funding the working capital requirements of the Company; General Corporate Purposes; Issue Expenses.
9.How can my company launch an IPO like Anlon Healthcare?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393